LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Computational MHC-I epitope predictor identifies 95% of experimentally mapped HIV-1 clade A and D epitopes in a Ugandan cohort.

    Bugembe, Daniel Lule / Ekii, Andrew Obuku / Ndembi, Nicaise / Serwanga, Jennifer / Kaleebu, Pontiano / Pala, Pietro

    BMC infectious diseases

    2020  Volume 20, Issue 1, Page(s) 172

    Abstract: Background: Identifying immunogens that induce HIV-1-specific immune responses is a lengthy process that can benefit from computational methods, which predict T-cell epitopes for various HLA types.: Methods: We tested the performance of the ... ...

    Abstract Background: Identifying immunogens that induce HIV-1-specific immune responses is a lengthy process that can benefit from computational methods, which predict T-cell epitopes for various HLA types.
    Methods: We tested the performance of the NetMHCpan4.0 computational neural network in re-identifying 93 T-cell epitopes that had been previously independently mapped using the whole proteome IFN-γ ELISPOT assays in 6 HLA class I typed Ugandan individuals infected with HIV-1 subtypes A1 and D. To provide a benchmark we compared the predictions for NetMHCpan4.0 to MHCflurry1.2.0 and NetCTL1.2.
    Results: NetMHCpan4.0 performed best correctly predicting 88 of the 93 experimentally mapped epitopes for a set length of 9-mer and matched HLA class I alleles. Receiver Operator Characteristic (ROC) analysis gave an area under the curve (AUC) of 0.928. Setting NetMHCpan4.0 to predict 11-14mer length did not improve the prediction (37-79 of 93 peptides) with an inverse correlation between the number of predictions and length set. Late time point peptides were significantly stronger binders than early peptides (Wilcoxon signed rank test: p = 0.0000005). MHCflurry1.2.0 similarly predicted all but 2 of the peptides that NetMHCpan4.0 predicted and NetCTL1.2 predicted only 14 of the 93 experimental peptides.
    Conclusion: NetMHCpan4.0 class I epitope predictions covered 95% of the epitope responses identified in six HIV-1 infected individuals, and would have reduced the number of experimental confirmatory tests by > 80%. Algorithmic epitope prediction in conjunction with HLA allele frequency information can cost-effectively assist immunogen design through minimizing the experimental effort.
    MeSH term(s) Adolescent ; Adult ; Child ; Cohort Studies ; Computational Biology/methods ; Enzyme-Linked Immunospot Assay ; Epitope Mapping/methods ; Epitopes, T-Lymphocyte/immunology ; Female ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/immunology ; Histocompatibility Antigens Class I/immunology ; Humans ; Male ; Middle Aged ; Neural Networks, Computer ; Peptides/immunology ; Uganda ; Young Adult
    Chemical Substances Epitopes, T-Lymphocyte ; Histocompatibility Antigens Class I ; Peptides
    Keywords covid19
    Language English
    Publishing date 2020-02-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041550-3
    ISSN 1471-2334 ; 1471-2334
    ISSN (online) 1471-2334
    ISSN 1471-2334
    DOI 10.1186/s12879-020-4876-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Alternate primers for whole-genome SARS-CoV-2 sequencing

    Cotten, Matthew / Bugembe, Daniel Lule / Kaleebu, Pontiano / Phan, My V.T.

    bioRxiv

    Abstract: As the world is struggling to control the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), there is an urgency to develop effective control measures. Essential information is encoded in the virus genome sequence with accurate and ... ...

    Abstract As the world is struggling to control the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), there is an urgency to develop effective control measures. Essential information is encoded in the virus genome sequence with accurate and complete SARS-CoV-2 sequences essential for tracking the movement and evolution of the virus and for guiding efforts to develop vaccines and antiviral drugs. While there is unprecedented SARS-CoV-2 sequencing efforts globally, approximately 19 to 43% of the genomes generated monthly are gapped, reducing their information content. The current study documents the genome gap frequencies and their positions in the currently available data and provides an alternative primer set and a sequencing scheme to helps improve the quality and coverage of the genomes.
    Keywords covid19
    Language English
    Publishing date 2020-10-12
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2020.10.12.335513
    Database COVID19

    Kategorien

  3. Article ; Online: SARS-CoV-2 Variants, South Sudan, January-March 2021.

    Bugembe, Daniel Lule / Phan, My V T / Abias, Abe G / Ayei, James / Deng, Lul Lojok / Lako, Richard Lino Loro / Rumunu, John / Kaleebu, Pontiano / Wamala, Joseph Francis / Hm, Juma John / Lodiongo, Dennis Kenyi / Bunga, Sudhir / Cotten, Matthew

    Emerging infectious diseases

    2021  Volume 27, Issue 12, Page(s) 3133–3136

    Abstract: As the coronavirus pandemic continues, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequence data are required to inform vaccine efforts. We provide SARS-CoV-2 sequence data from South Sudan and document the dominance of SARS-CoV-2 ... ...

    Abstract As the coronavirus pandemic continues, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequence data are required to inform vaccine efforts. We provide SARS-CoV-2 sequence data from South Sudan and document the dominance of SARS-CoV-2 lineage B.1.525 (Eta variant) during the country's second wave of infection.
    MeSH term(s) COVID-19 ; Humans ; Pandemics ; SARS-CoV-2 ; South Sudan/epidemiology
    Language English
    Publishing date 2021-10-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid2712.211488
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda.

    Bugembe, Daniel Lule / Phan, My V T / Ssewanyana, Isaac / Semanda, Patrick / Nansumba, Hellen / Dhaala, Beatrice / Nabadda, Susan / O'Toole, Áine Niamh / Rambaut, Andrew / Kaleebu, Pontiano / Cotten, Matthew

    Nature microbiology

    2021  Volume 6, Issue 8, Page(s) 1094–1101

    Abstract: Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 ... ...

    Abstract Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in Uganda, a landlocked East African country with a population of approximately 40 million people. We report 322 full SARS-CoV-2 genomes from 39,424 reported SARS-CoV-2 infections, thus representing 0.8% of the reported cases. Phylogenetic analyses of these sequences revealed the emergence of lineage A.23.1 from lineage A.23. Lineage A.23.1 represented 88% of the genomes observed in December 2020, then 100% of the genomes observed in January 2021. The A.23.1 lineage was also reported in 26 other countries. Although the precise changes in A.23.1 differ from those reported in the first three SARS-CoV-2 variants of concern (VOCs), the A.23.1 spike-protein-coding region has changes similar to VOCs including a change at position 613, a change in the furin cleavage site that extends the basic amino acid motif and multiple changes in the immunogenic N-terminal domain. In addition, the A.23.1 lineage has changes in non-spike proteins including nsp6, ORF8 and ORF9 that are also altered in other VOCs. The clinical impact of the A.23.1 variant is not yet clear and it has not been designated as a VOC. However, our findings of emergence and spread of this variant indicate that careful monitoring of this variant, together with assessment of the consequences of the spike protein changes for COVID-19 vaccine performance, are advisable.
    MeSH term(s) Amino Acid Motifs ; COVID-19/epidemiology ; Coronavirus Nucleocapsid Proteins/genetics ; Genetic Variation/genetics ; Genome, Viral/genetics ; Humans ; Phosphoproteins/genetics ; Phylogeny ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus/genetics ; Uganda/epidemiology ; Viral Proteins/genetics
    Chemical Substances Coronavirus Nucleocapsid Proteins ; NSP6 protein, SARS-CoV-2 ; ORF8 protein, SARS-CoV-2 ; Phosphoproteins ; Spike Glycoprotein, Coronavirus ; Viral Proteins ; nucleocapsid phosphoprotein, SARS-CoV-2 ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2021-06-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2058-5276
    ISSN (online) 2058-5276
    DOI 10.1038/s41564-021-00933-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic

    Lule Bugembe, Daniel / Phan, My V.T. / Ssewanyana, Isaac / Semanda, Patrick / Nansumba, Hellen / Dhaala, Beatrice / Nabadda, Susan / O'Toole, Aine / Rambaut, Andrew / Kaleebu, Pontiano / Cotten, Matthew

    medRxiv

    Abstract: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in March 2020 in Uganda. Recently the epidemic showed a shift of SARS-CoV-2 variant distribution and we report here newly emerging A sub-lineages, A.23 and A.23.1, ... ...

    Abstract The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in March 2020 in Uganda. Recently the epidemic showed a shift of SARS-CoV-2 variant distribution and we report here newly emerging A sub-lineages, A.23 and A.23.1, encoding replacements in the spike protein, nsp6, ORF8 and ORF9, with A.23.1 the major virus lineage now observed in Kampala. Although the clinical impact of the A.23.1 variant is not yet clear it is essential to continue careful monitoring of this variant, as well as rapid assessment of the consequences of the spike protein changes for vaccine efficacy.
    Keywords covid19
    Language English
    Publishing date 2021-02-11
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.02.08.21251393
    Database COVID19

    Kategorien

  6. Article ; Online: Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.

    Bugembe, Daniel Lule / Kayiwa, John / Phan, My V T / Tushabe, Phiona / Balinandi, Stephen / Dhaala, Beatrice / Lexow, Jonas / Mwebesa, Henry / Aceng, Jane / Kyobe, Henry / Ssemwanga, Deogratius / Lutwama, Julius / Kaleebu, Pontiano / Cotten, Matthew

    Emerging infectious diseases

    2020  Volume 26, Issue 10, Page(s) 2411–2415

    Abstract: We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an ... ...

    Abstract We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an important baseline for tracking any further transmission of the virus throughout the country and region.
    MeSH term(s) Air Travel ; Betacoronavirus/genetics ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Coronavirus Infections/virology ; Genetic Variation ; Genome ; Health Policy ; Humans ; Mass Screening ; Motor Vehicles ; Pandemics/prevention & control ; Phylogeography ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/virology ; Quarantine ; SARS-CoV-2 ; Uganda/epidemiology
    Keywords covid19
    Language English
    Publishing date 2020-07-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid2610.202575
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: SARS-CoV-2 Variants, South Sudan, January–March 2021

    Daniel Lule Bugembe / My V.T. Phan / Abe G. Abias / James Ayei / Lul Lojok Deng / Richard Lino Loro Lako / John Rumunu / Pontiano Kaleebu / Joseph Francis Wamala / Juma John HM / Dennis Kenyi Lodiongo / Sudhir Bunga / Matthew Cotten

    Emerging Infectious Diseases, Vol 27, Iss 12, Pp 3133-

    2021  Volume 3136

    Abstract: As the coronavirus pandemic continues, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequence data are required to inform vaccine efforts. We provide SARS-CoV-2 sequence data from South Sudan and document the dominance of SARS-CoV-2 ... ...

    Abstract As the coronavirus pandemic continues, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequence data are required to inform vaccine efforts. We provide SARS-CoV-2 sequence data from South Sudan and document the dominance of SARS-CoV-2 lineage B.1.525 (Eta variant) during the country's second wave of infection.
    Keywords COVID-19 ; coronavirus disease ; SARS-CoV-2 ; severe acute respiratory syndrome coronavirus 2 ; viruses ; respiratory infections ; Medicine ; R ; Infectious and parasitic diseases ; RC109-216
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher Centers for Disease Control and Prevention
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda

    Daniel Lule Bugembe / John Kayiwa / My V.T. Phan / Phiona Tushabe / Stephen Balinandi / Beatrice Dhaala / Jonas Lexow / Henry Mwebesa / Jane Aceng / Henry Kyobe / Deogratius Ssemwanga / Julius Lutwama / Pontiano Kaleebu / Matthew Cotten

    Emerging Infectious Diseases, Vol 26, Iss 10, Pp 2411-

    2020  Volume 2415

    Abstract: We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an ... ...

    Abstract We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an important baseline for tracking any further transmission of the virus throughout the country and region.
    Keywords COVID-19 ; 2019 novel coronavirus disease ; SARS-CoV-2 ; severe acute respiratory syndrome coronavirus 2 ; viruses ; respiratory infections ; Medicine ; R ; Infectious and parasitic diseases ; RC109-216 ; covid19
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher Centers for Disease Control and Prevention
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article: Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda

    Bugembe, Daniel Lule / Kayiwa, John / Phan, My V T / Tushabe, Phiona / Balinandi, Stephen / Dhaala, Beatrice / Lexow, Jonas / Mwebesa, Henry / Aceng, Jane / Kyobe, Henry / Ssemwanga, Deogratius / Lutwama, Julius / Kaleebu, Pontiano / Cotten, Matthew

    Emerg Infect Dis

    Abstract: We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an ... ...

    Abstract We established rapid local viral sequencing to document the genomic diversity of severe acute respiratory syndrome coronavirus 2 entering Uganda. Virus lineages closely followed the travel origins of infected persons. Our sequence data provide an important baseline for tracking any further transmission of the virus throughout the country and region.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #625963
    Database COVID19

    Kategorien

  10. Article ; Online: Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials.

    Kebba, Anthony / Imami, Nesrina / Bugembe-Lule, Daniel / Senkaali, David / Kaleebu, Pontiano / Grosskurth, Heiner / Gotch, Frances

    Pharmacogenomics

    2007  Volume 8, Issue 4, Page(s) 409–414

    Abstract: Assessment of vaccine efficacy on end points used in Phase IIB test-of-concept trials will require taking into consideration the effect of variables correlated with the end points and distribution of the variables within subgroups of the trial population. ...

    Abstract Assessment of vaccine efficacy on end points used in Phase IIB test-of-concept trials will require taking into consideration the effect of variables correlated with the end points and distribution of the variables within subgroups of the trial population. Here we report that evaluation of sexual activity in vaccinees and longitudinal collection of plasma viral load data from putative transmitters prior to transmission will contribute to the plausible assessment of efficacy against acquisition of infection. Data also suggest that efficacy on post-infection end points may depend on whether transmission pairs are matched or mismatched for HLA class I alleles.
    MeSH term(s) AIDS Vaccines/therapeutic use ; Adult ; Cohort Studies ; Female ; Follow-Up Studies ; HIV Infections/blood ; HIV Infections/drug therapy ; HIV Infections/prevention & control ; HIV-1 ; Humans ; Male ; Risk Factors ; Uganda/epidemiology ; Viral Load/methods
    Chemical Substances AIDS Vaccines
    Language English
    Publishing date 2007-03-27
    Publishing country England
    Document type Clinical Trial, Phase II ; Comparative Study ; Journal Article
    ZDB-ID 2019513-8
    ISSN 1744-8042 ; 1462-2416
    ISSN (online) 1744-8042
    ISSN 1462-2416
    DOI 10.2217/14622416.8.4.409
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top